Uae Vaccines: Available Options For Health And Protection In 2023

what are the vaccine available in uae

The United Arab Emirates (UAE) has made significant strides in ensuring public health through a robust vaccination program, offering a wide range of vaccines to its residents and citizens. With a focus on preventive healthcare, the UAE provides access to vaccines for various diseases, including COVID-19, influenza, hepatitis, measles, mumps, rubella, and more. The country's health authorities, such as the Ministry of Health and Prevention (MOHAP) and the Department of Health – Abu Dhabi (DoH), regularly update their vaccine portfolios to include the latest advancements and recommendations from global health organizations. As of recent updates, the UAE has approved and distributed several COVID-19 vaccines, including Pfizer-BioNTech, Sinopharm, AstraZeneca, and Moderna, ensuring widespread coverage and protection against the virus. Additionally, routine immunization schedules for children and adults are strictly followed, with vaccines available at government health centers, private clinics, and specialized vaccination drives. The UAE's commitment to vaccination is evident in its high immunization rates and proactive approach to public health, making it a leader in regional healthcare initiatives.

bankshun

COVID-19 Vaccines: Pfizer-BioNTech, Sinopharm, AstraZeneca, Moderna, Sputnik V available across UAE healthcare centers

The UAE has been at the forefront of the global fight against COVID-19, offering a diverse range of vaccines to its residents and citizens. Among the most prominent are Pfizer-BioNTech, Sinopharm, AstraZeneca, Moderna, and Sputnik V, each available across various healthcare centers nationwide. This variety ensures accessibility and caters to different preferences and medical needs, reflecting the country’s commitment to public health.

Pfizer-BioNTech, a mRNA vaccine, is widely administered in the UAE, particularly to individuals aged 12 and above. It requires two doses, typically given 21 days apart, with a booster recommended after six months. Its high efficacy rate, reported at around 95% against severe illness, has made it a preferred choice for many. Parents should note that the dosage for adolescents (12–17 years) is the same as for adults, but careful monitoring is advised post-vaccination. For those with busy schedules, booking appointments through the SEHA or MOHAP apps can streamline the process.

Sinopharm, developed by China’s Sinopharm, is another cornerstone of the UAE’s vaccination campaign. It is administered in two doses, 21–28 days apart, and is approved for individuals aged 3 and above. Its widespread use in the UAE is partly due to its early availability and the country’s participation in its Phase III trials. While its efficacy rate varies globally, the UAE has reported robust protection, especially against severe outcomes. For families, Sinopharm’s approval for younger children makes it a practical option, though parents should consult healthcare providers for personalized advice.

AstraZeneca, also known as Covishield in some regions, is available for those aged 18 and above. It follows a two-dose regimen, with an interval of 8–12 weeks between doses. While it has faced scrutiny in some countries due to rare side effects, the UAE has continued its distribution, emphasizing its effectiveness in preventing hospitalization and death. Individuals with a history of blood clots should discuss their medical history with a healthcare professional before receiving this vaccine.

Moderna, another mRNA vaccine, is offered as an alternative to Pfizer-BioNTech, particularly for those aged 18 and above. It requires two doses, administered 28 days apart, with a booster advised after six months. Moderna’s slightly higher dosage compared to Pfizer-BioNTech has been linked to slightly stronger side effects, such as fatigue and muscle pain, but these are generally mild and short-lived. For individuals with specific mRNA vaccine preferences, Moderna provides a viable option, though availability may vary across centers.

Sputnik V, developed by Russia’s Gamaleya Research Institute, is a two-dose vaccine with a 21-day interval. Approved for individuals aged 18 and above, it uses a unique heterologous approach, combining two different adenovirus vectors. Its efficacy rate of around 92% has garnered attention, and the UAE’s inclusion of Sputnik V highlights its strategy to diversify vaccine options. Those opting for Sputnik V should be aware of potential side effects, such as fever and headache, which are typically manageable with rest and hydration.

In summary, the UAE’s healthcare centers offer a comprehensive array of COVID-19 vaccines, each with distinct characteristics and suitability criteria. Whether it’s the mRNA technology of Pfizer-BioNTech and Moderna, the adenovirus-based AstraZeneca and Sputnik V, or the inactivated virus approach of Sinopharm, residents have the flexibility to choose based on age, health status, and personal preference. By providing such variety, the UAE ensures that its vaccination drive remains inclusive and effective, safeguarding public health in the face of the pandemic.

bankshun

Childhood Vaccines: Mandatory immunizations for children, including MMR, polio, and hepatitis vaccines

In the UAE, childhood vaccines are a cornerstone of public health, with mandatory immunizations designed to protect children from preventable diseases. The national vaccination program includes critical vaccines such as MMR (Measles, Mumps, and Rubella), polio, and hepatitis, administered in a structured schedule to ensure maximum efficacy. For instance, the MMR vaccine is typically given in two doses: the first at 12 months and the second between 18 to 24 months. This schedule aligns with global health standards and is rigorously enforced to maintain high immunity levels across the population.

Analyzing the impact of these vaccines reveals their profound role in disease eradication. Polio, once a global menace, has been nearly eliminated in the UAE due to consistent vaccination efforts. The oral polio vaccine (OPV) is administered at birth, followed by three additional doses at 2, 4, and 6 months, with a booster at 18 months. This regimen ensures robust protection against the virus, preventing its resurgence. Similarly, the hepatitis B vaccine, given at birth, 1 month, and 6 months, safeguards children from a virus that can lead to chronic liver disease, demonstrating the long-term benefits of early immunization.

From a practical standpoint, parents must adhere to the UAE’s vaccination schedule to ensure their children’s health and compliance with school enrollment requirements. Missed doses can be caught up through consultation with healthcare providers, who often use combination vaccines to streamline the process. For example, the MMR vaccine is sometimes combined with varicella (chickenpox) protection, reducing the number of injections needed. Additionally, maintaining a vaccination record is essential, as it serves as proof of immunization and helps track future booster needs.

Comparatively, the UAE’s approach to childhood vaccines stands out for its accessibility and rigor. Unlike some countries where vaccine hesitancy poses challenges, the UAE mandates these immunizations, ensuring high coverage rates. This policy not only protects individual children but also contributes to herd immunity, shielding vulnerable populations who cannot be vaccinated due to medical reasons. The integration of these vaccines into routine healthcare underscores their importance in fostering a healthier society.

In conclusion, the UAE’s mandatory childhood vaccines, including MMR, polio, and hepatitis, are a testament to the nation’s commitment to public health. By following the prescribed schedules and staying informed, parents play a vital role in safeguarding their children’s future. These vaccines not only prevent diseases but also pave the way for a healthier, more resilient community. Practical adherence and awareness are key to maximizing their benefits, ensuring that every child grows up protected.

bankshun

Travel Vaccines: Yellow fever, typhoid, and meningitis vaccines for international travelers from the UAE

International travelers from the UAE must prioritize specific vaccines to protect against diseases prevalent in their destinations. Among these, yellow fever, typhoid, and meningitis vaccines are critical for regions where these illnesses are endemic. Yellow fever, a viral disease transmitted by mosquitoes, is required for entry into certain African and South American countries. The UAE offers the yellow fever vaccine, typically administered as a single dose providing lifelong immunity, at designated clinics approved by the Ministry of Health and Prevention. Travelers should receive this vaccine at least 10 days before departure to ensure compliance with international health regulations.

Typhoid fever, caused by the bacterium Salmonella Typhi, is common in areas with poor sanitation. The typhoid vaccine is available in the UAE in two forms: an injectable polysaccharide vaccine for individuals aged 2 and older, and an oral vaccine suitable for those aged 6 and above. The injectable version requires a single dose, while the oral vaccine is administered in four doses over a week. Travelers to South Asia, Africa, and Latin America should consider this vaccine, especially if their itinerary includes rural or high-risk areas. It’s essential to complete the vaccination series at least one week before travel for optimal protection.

Meningitis vaccines are another critical consideration, particularly for travelers visiting the meningitis belt in sub-Saharan Africa or participating in mass gatherings like the Hajj or Umrah. The UAE provides the meningococcal vaccine, which protects against strains A, C, W, and Y. This vaccine is recommended for individuals aged 2 and older, with a single dose offering protection for up to five years. Travelers should consult healthcare providers to determine if additional vaccines, such as the meningitis B vaccine, are necessary based on their destination and activities.

Practical tips for UAE residents include verifying vaccination requirements with embassies or travel clinics well in advance, as some countries mandate proof of vaccination upon entry. Additionally, travelers should carry their International Certificate of Vaccination (yellow card) for yellow fever, as it is often required at border crossings. Combining these vaccines with general travel health advice, such as mosquito avoidance and safe food practices, maximizes protection. By staying informed and proactive, travelers from the UAE can safeguard their health while exploring the world.

bankshun

Seasonal Vaccines: Annual flu vaccines offered at clinics and pharmacies nationwide during flu season

In the UAE, as the cooler months approach, the annual flu vaccine becomes a cornerstone of public health strategy. Clinics and pharmacies nationwide gear up to administer these seasonal vaccines, typically available from October through March, aligning with the peak flu season. The Ministry of Health and Prevention (MoHAP) and the Department of Health Abu Dhabi (DoH) recommend the flu vaccine for all residents, particularly those in high-risk groups such as children aged 6 months to 5 years, pregnant women, adults over 65, and individuals with chronic conditions like asthma, diabetes, or heart disease. The vaccine is designed to protect against the most prevalent influenza strains predicted for the season, as determined by global health organizations like the World Health Organization (WHO).

The process of getting a flu vaccine in the UAE is straightforward and accessible. Most clinics and pharmacies offer the vaccine without requiring a prior appointment, though booking ahead can save time. The vaccine is administered via a single intramuscular injection, typically in the upper arm, and is available in two primary formulations: the inactivated influenza vaccine (IIV) for individuals aged 6 months and older, and the live attenuated influenza vaccine (LAIV), a nasal spray option for healthy, non-pregnant individuals aged 2 to 49. The cost varies, with many employers and insurance providers covering the expense, while public health centers often offer it at a subsidized rate or free of charge.

One of the key advantages of the annual flu vaccine is its ability to reduce the severity and duration of illness, even if a vaccinated individual contracts the flu. Studies show that vaccinated individuals are less likely to experience severe complications such as pneumonia or hospitalization. For example, during the 2022-2023 flu season, the UAE reported a 40% reduction in flu-related hospitalizations among vaccinated individuals compared to the unvaccinated population. This underscores the vaccine’s role not only in personal protection but also in reducing the strain on healthcare systems.

Practical tips for maximizing the vaccine’s effectiveness include scheduling the shot early in the flu season to ensure immunity throughout the peak months. It’s also advisable to avoid the vaccine if you have a moderate or severe illness with a fever, though minor illnesses like a cold are not contraindications. After vaccination, mild side effects such as soreness at the injection site, low-grade fever, or muscle aches may occur but typically resolve within 1-2 days. Staying hydrated and resting can help alleviate these symptoms.

In comparison to other vaccines available in the UAE, the seasonal flu vaccine stands out for its annual reformulation, reflecting the evolving nature of influenza viruses. Unlike vaccines for diseases like measles or hepatitis, which provide long-term immunity after a series of doses, the flu vaccine requires yearly administration due to the virus’s rapid mutation. This makes it a unique yet essential component of preventive healthcare in the UAE, emphasizing the importance of staying updated with public health recommendations each season. By prioritizing this simple yet effective measure, individuals contribute to both their own well-being and the broader community’s resilience against seasonal outbreaks.

bankshun

Specialized Vaccines: HPV, shingles, and pneumonia vaccines available for specific age groups and conditions

The UAE's vaccination landscape extends beyond routine immunizations, offering specialized vaccines tailored to specific age groups and health conditions. Among these are the HPV, shingles, and pneumonia vaccines, each addressing distinct health concerns with targeted protection. Understanding their availability, eligibility, and administration protocols is crucial for informed decision-making.

HPV Vaccine: Preventing Cervical Cancer and Beyond

The Human Papillomavirus (HPV) vaccine is a cornerstone in preventing cervical cancer, genital warts, and other HPV-related cancers. In the UAE, it is recommended for adolescents aged 9 to 14, with a two-dose schedule administered 6 to 12 months apart. For individuals aged 15 and older, a three-dose regimen is required, spaced over 6 months. Notably, the UAE’s health authorities emphasize early vaccination, as it is most effective before potential exposure to the virus. Parents and guardians are encouraged to consult healthcare providers to determine the optimal timing for their children, ensuring long-term protection against HPV-associated diseases.

Shingles Vaccine: Shielding Older Adults from Painful Outbreaks

Shingles, caused by the reactivation of the varicella-zoster virus, can lead to severe pain and complications, particularly in older adults. The UAE offers the shingles vaccine, specifically recommended for individuals aged 50 and above. A single dose of the recombinant zoster vaccine (RZV) provides robust protection, reducing the risk of shingles by over 90%. Unlike the HPV vaccine, shingles vaccination does not require multiple doses, making it a straightforward preventive measure. However, individuals with weakened immune systems should consult their doctor before vaccination, as specific health conditions may affect eligibility.

Pneumonia Vaccine: Tailored Protection for High-Risk Groups

Pneumococcal vaccines in the UAE cater to both children and adults, with different formulations addressing varying needs. For infants and young children, the 13-valent pneumococcal conjugate vaccine (PCV13) is administered in a series of doses starting at 2 months of age. Adults aged 65 and older, as well as those with chronic conditions like diabetes, heart disease, or compromised immune systems, are eligible for the 23-valent pneumococcal polysaccharide vaccine (PPSV23). A key consideration is the timing between these vaccines; adults who receive PCV13 should wait at least one year before getting PPSV23. This staggered approach ensures comprehensive protection against pneumococcal infections, which can be life-threatening in vulnerable populations.

Practical Tips for Accessing Specialized Vaccines

In the UAE, these specialized vaccines are available at government health centers, private clinics, and pharmacies, often covered by insurance plans. Scheduling appointments in advance is advisable, as some vaccines may require specific storage conditions or limited availability. Additionally, maintaining a vaccination record is essential, particularly for multi-dose regimens like the HPV vaccine. For travelers or expatriates, verifying vaccine availability and eligibility criteria with local healthcare providers ensures seamless access to these critical preventive measures.

Specialized vaccines like HPV, shingles, and pneumonia shots exemplify the UAE’s commitment to targeted public health initiatives. By understanding their unique applications and administration guidelines, individuals can take proactive steps to safeguard their health and well-being. Whether for adolescents, older adults, or those with specific health conditions, these vaccines offer tailored protection against preventable diseases, underscoring the importance of informed healthcare decisions.

Frequently asked questions

The UAE offers several COVID-19 vaccines, including Pfizer-BioNTech, Sinopharm, AstraZeneca, and Sputnik V. These vaccines are approved by the Ministry of Health and Prevention (MoHAP) and are widely available across the country.

Yes, the UAE has approved the Pfizer-BioNTech COVID-19 vaccine for children aged 5 and above. Additionally, routine childhood vaccinations, such as MMR, polio, and hepatitis, are available at public and private healthcare facilities.

Yes, the UAE provides COVID-19 vaccines free of charge to all residents, including expatriates, as part of its national vaccination campaign. Other routine vaccines may have associated costs, depending on the healthcare provider.

Yes, booster doses for COVID-19 are available in the UAE. Eligibility criteria vary, but generally, individuals who have completed their primary vaccination series (usually 6 months after the second dose) are encouraged to get a booster. Priority is often given to vulnerable groups, such as the elderly and those with comorbidities.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment